Therapeutics News and Research

RSS

UC Davis Health and Propeller Health join forces to offer personalized treatment for patients with asthma, COPD

UC Davis Health and Propeller Health have announced a new collaboration that will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease (COPD) aiming to improve their health outcomes.

28 Mar 2023

Notorious oncogene plays a direct role in disguising growing cancers from the immune system

Cancer-associated genes called oncogenes are well known to stimulate cell growth and division — causing tumors to balloon and spread.

28 Mar 2023

CBD-based compounds boost the effects of naloxone

There's been a recent push in the U.S. to make naloxone - a fast-acting opioid antidote - available without a prescription.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group plc today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division.

From Avacta Life Sciences Ltd. 28 Mar 2023

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.

27 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code.

27 Mar 2023

Advancements in understanding and treating breast cancer

Researchers describe recent advancements in breast cancer research.

26 Mar 2023

Circadian rhythms govern cancer progression and metastasis

Your circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment.

24 Mar 2023

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

Newly developed mRNA vaccines against Zika virus and HIV-1 produced strong antibody responses that transferred from pregnant rabbits to their offspring, researchers report March 24th in the journal Molecular Therapy.

24 Mar 2023

Candida auris escapes innate immunity through metabolic reprogramming

A team of scientists from Australia and Israel demonstrates that Candida auris, a fungus associated with life-threatening and drug-resistant infections, escapes the host's innate immune response by destroying macrophages through metabolic reprogramming. The fungus is also capable of escaping antimicrobial inflammatory response.

23 Mar 2023

Understanding the structure of CFTR could help design more effective therapies for cystic fibrosis

Scientists at St. Jude Children's Research Hospital and Rockefeller University have combined their expertise to gain a better understanding of the cystic fibrosis transmembrane conductance regulator (CFTR).

23 Mar 2023

Researchers discover how a mutation in the desmosomal gene leads to arrhythmogenic cardiomyopathy

Mutations in genes that form the desmosome are the most common cause of the cardiac disease arrhythmogenic cardiomyopathy (ACM), which affects one in 2000 to 5000 people worldwide.

22 Mar 2023

Keeping stem cells clean and tidy is an integral step to promoting a long healthspan

In humanity's ongoing quest for the elixir of life, the science keeps pointing to stem cells. Research increasingly shows that maintaining stem cell fitness promotes a long healthspan, and new findings show keeping stem cells clean and tidy is an integral step.

21 Mar 2023

Snapping at new biotech breakthroughs with Gator Pro

In this interview, we speak to Subodh Nimkar, Marketing Director at Gator Bio, about their latest technology, Gator Pro which allows for fast, reliable, and high-quality data.

From Gator Bio, Inc. 21 Mar 2023

Novel RNA sense-and-respond circuit harnesses the force of enzymes to develop better drugs

More than twelve billion doses of mRNA vaccines have been administered globally since the start of the COVID pandemic, saving millions of lives. But RNA-based therapies for other diseases have so far proven more challenging to develop.

20 Mar 2023

Upgraded tumor model points the way toward more effective cancer therapies

Tumor cells won't show their true selves in a petri dish, isolated from other cells.

20 Mar 2023

UK Government names two leaders to spearhead new Dementia Mission

The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia, which was launched in memory of the late Dame Barbara Windsor.

20 Mar 2023

Novel immunotherapeutic strategies to target the complex tumor immune microenvironment in head and neck cancer

A symposium aiming to provide a better understanding of the tumor microenvironment, immune tolerogenic niches at cancer initiation, and novel immunotherapeutic strategies in head and neck cancer patients was featured at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR.

20 Mar 2023

Therapeutics News and Research

UC Davis Health and Propeller Health join forces to offer personalized treatment for patients with asthma, COPD

Notorious oncogene plays a direct role in disguising growing cancers from the immune system

CBD-based compounds boost the effects of naloxone

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

New study suggests broad neutralizing antibody could provide three years of COVID protection

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

Advancements in understanding and treating breast cancer

Circadian rhythms govern cancer progression and metastasis

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

Candida auris escapes innate immunity through metabolic reprogramming

Understanding the structure of CFTR could help design more effective therapies for cystic fibrosis

Researchers discover how a mutation in the desmosomal gene leads to arrhythmogenic cardiomyopathy

Keeping stem cells clean and tidy is an integral step to promoting a long healthspan

Snapping at new biotech breakthroughs with Gator Pro

Novel RNA sense-and-respond circuit harnesses the force of enzymes to develop better drugs

Upgraded tumor model points the way toward more effective cancer therapies

UK Government names two leaders to spearhead new Dementia Mission

Novel immunotherapeutic strategies to target the complex tumor immune microenvironment in head and neck cancer

Advancing therapeutic biopolymer development eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News